KOSPI · Healthcare · ₩247B
₩18,440-0.59%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 6.0% · as of 26.09.11
Among 98 제약 peers
Quarterly Revenue Growth
“기존 의약품이 중심이고 신약은 다음 기회를 준비해요.”
In the company's words · 2026 2분기 filing